Scientific Poster Session III - Clinical Pharmacy Forum

Abstract

Justification/Documentation: Asthma remains a significant public health issue, often exacerbated by suboptimal medication use and management strategies. This program addresses the need for enhanced asthma management by leveraging the expertise of clinical pharmacists. The effectiveness of the program is evidenced by quantitative measures, including an increased AMR and higher rates of SMART therapy prescriptions. Preliminary results indicate a 5% improvement in patients reaching AMR goals and a 51% increase in SMART prescribing. Qualitative feedback from patients highlights improved asthma control and patient satisfaction.

Adaptability: The SMART AMR program is designed to be generalizable across various healthcare settings. The use of CDSTs is integral, ensuring that the program can be seamlessly implemented in other healthcare networks with similar resources. It is tailored to the needs of the asthma patient population and can be delivered by equivalently qualified clinical pharmacists in collaboration with healthcare teams.

Significance: The SMART AMR program advances the role of clinical pharmacists in optimizing asthma care. By demonstrating the impact on AMR and the adoption of SMART therapy, it underscores the value of pharmacists on population health teams. The program provides a model that can be replicated and scaled to enhance asthma care surrounding patient satisfaction, quality metrics, and clinical outcomes.

Presenting Author

Authors